An Australian study has revealed that the country’s prevalence of vision loss due to Leber hereditary optic neuropathy (LHON) is at least one in 68,403. LHON...

Julie-Anne Davies’ picture of a ‘Ladakhi weaver’ won the professional award at this year’s International Agency for the Prevention of Blindness (IAPB)...

Sight Sciences’ TearCare system for the treatment of meibomian gland dysfunction (MGD) has received the US Food and Drug Administration’s (FDA) 510(K)...

A trial of 108 children with severe amblyopia has shown that combined atropine and patching therapy (CAPT) showed superior improvement in visual acuity...

Amazon founder and executive chair Jeff Bezos is rumoured to have ptosis in his right eye, or possibly a bulging left eye. The online speculation seems...

Xipere, the first product for injection into the suprachoroidal space to treat macular oedema associated with uveitis, has been granted US Food and Drug...

Mitomycin C (MMC), applied to inhibit incoming keratocytes after corneal crosslinking (CXL), increases corneal haze, according to the authors of a study...

Corneal cells propagated in vitro can be injected into the cornea to restore vision to patients blinded by corneal endothelial disease, reported Aurion...

OcuTerra Therapeutics has commenced phase 1b clinical trials of its OTT166 eye drops for patients with diabetic retinopathy (DR) and wet AMD, having demonstrated...

Researchers at the University of Sydney said their Phoenix99 bionic eye implant is ready for human trials, having demonstrated its safety in a three-month...

A smartphone video app can be used to evaluate concussion patients for recovery and measure compounding injuries, a new study found.   The app, Reflex, identifies...

Dutch start-up Hable has released a braille keyboard, Hable One, that fits in the palm of your hand.   “Our vision is to make smartphones completely accessible...